There have been many reports indicating that estradiol has a positive as well as negative feedback effect on gonadotropin secretion in the hypothalamo-pituitary axis, but the sites of the action have not been fully understood.
In the rat, it has been shown that estradiol can inhibit gonadotropin secretion by a direct action on the pituitary (Bogdanove, 1963; De Koning et al., 1976) . In humans, Keye and Jaffe (1974) and Thompson et al. (1976) reported evidence in favor of this view by showing blunted responses to exogenous LH-RH given to women during the administration of estrogen.
On the other hand, only a few researchers have indicated that estrogen could evoke a gonadotropin surge by acting at the level of the pituitary gland in humans . Ferin et al. (1979) 
Materials and Methods

Subjects
Six castrated women (ranging in age from 35 to 40) who had undergone hysterectomy with bilateral salpingo-oophorectomy for uterine fibroma or carcimona one month or more before this study and two hypogonadal women (age 22 and 29, respectively) who were diagnosed by the laboratory data and pathologic examinations, participated in this study. These subjects were informed about the nature of this study, and consent was obtained.
Methods
Experiment 1: Three castrated women were hospitalized, and an intravenous cannula (Argyle 18G) was inserted into an antecubital vein. The cannula was connected via a L-type three-way stopcock to the infusion line of 500 ml of saline which contained 1000 units of sodium heparin as an anticoagulant.
The Hormonal analysis Plasma LH and FSH: Plasma LH and FSH levels were measured in duplicate using a radioimmunoassay kit (Daiichi Isotope Co., Japan) and were expressed as mIU/ml 2nd IRP-hMG. The average intraassay coefficients of variation (CVs) of LH and ESH were 8.5% and 9.2% (n= 21), and the average interassay CVs were 17% and 16% (n= 21) respectively. The limit of sensitivity of each assay was 2.0 mIU/ml.
Plasma estradiol: Plasma estradiol levels were also measured using a radioimmunoassay kit (Midorijuji Co., Japan). The average intraand interassay CVs were 9.3% (n=31) and 20% (n= 17) respectively. The limit of sensitivity of the assay was 12.5 pg/ml. Karsh et al., 1973) and in humans (Tompson et al., 1974; Araki et al., 1978) . Based on these experimental data, especially in rhesus monkeys, Knobil (1974) concluded that the developement of the positive feedback, which played an important role in spontaneous preovulatory LH surges, was dependent not simply on a critical threshold concentration of circulating estradiol (approximately 100 pg/ml in peripheral plasma concentration), but also on an important time component (12-42 hours), and mentioned that the negative feedback was operative with subthreshold levels of estradiol or brief exposure periods.
In addition to these observations, Jewelwitz et al., (1974) On the other hand, thd availability of synthetic Gn-RH (Matsuo et al., 1971 ) for laboratory and clinical investigations gave rise to new possibilities for further detailed, examinations of pituitary gonadotropin release, and the augumentation of pituitary responsiveness to Gn-RH by estrogen was recognized to exist in animals (Arimura and Schally, 1971) and in humans (Yen et al., 1972) during the high estrogenic phase of the menstrual cycle. As regards exogenous estrogen administration, many reports have been published to support the effects of estrogen on pituitary resposiveness to synthetic Gn-RH, and the authors agreed with the opinion that estrogen had biphasic effects on the pituitary responsiveness to Gn-RH, depending upon the dose and duration of administration of the estrogen (Libertun et al., 1974; Young and Jaffe, 1976) , the early effect being inhibitory and the latter being stimulatory, but they could not all agree about the site of estrogen action (Yen and Lein, 1976; Aiyer et al., 1973) . Considering the possibility of endogenous Gn-RH fluctuations by the administration of estrogen, we should carefully draw our conclusions about the effects of estrogen on the resposiveness to Gn-RH at the pituitary level.
Concerning the remaining problems, endogenous Gn-RH fluctuations in pituitary portal blood have become of world-wide interest. The development of radioimmunoassay for Gn-RH (Nett et al., 1973; Tamada et al., 1973) has made it possible to measure the concentrations of Gn-RH in peripheral plasma and to explain the physiological significances of endogenous Gn-RH. There are several reports on the peripheral plasma Gn-RH concentration in normal women (Jones et al., 1975) and in women with various endocrinological conditions (Rosemblum and Schlaff, 1976; Kawamura et al., 1980; Miyake et al., 1980) . These authors have concluded that high levels of plasma Gn-RH were recognized at the midcycle in normal women, in women with secondary amenorrhea, Sheehan's syndrome and Turner's syndrome, and in postmenopausal women. These data suggest that the release of a greater amount of Gn-RH from the hypothalamus into the pituitary portal vessels plays an important part in pre-ovulatory gonadotropin discharge.
More advanced studies have been carried out in animals to measure Gn-RH concentrations in pituitary portal blood (Carmel et al., 1976) , and they have revealed considerable fluctuations in the concentration of Gn-RH in the portal blood as pulsatile and episodic secretions. These data showed clearly that hypothalamic Gn-RH played an important part in the pituitary gonadotropin release and the manner of the release. Finally, we have concluded in agreement with the results of Labrie et al., (1978) , that three important factors (1) increased Gn-RH secretion or pulse rate induced by circulating estrogen (levels and duration), (2) increased gonadotropin responsiveness to Gn-RH induced by estrogen (levels), and (3) increased gonadotropin responsiveness to Gn-RH induced by Gn-RH itself, should contribute to the preovulatory gonadotropin surges in normal females, and we are of the opinion that the first two factors are more important and effective in preovulatory gonadotropin surges.
